de
Financial Reports
Financial Reports 2010/2011
Financial Reports 2009/2010
Archive
Financial Reports 2008/2009
Financial Reports 2007/2008
Financial Reports 2006/2007
Financial Reports 2005/2006
Financial Reports 2004/2005
Financial Reports 2003/2004
Financial Reports 2002/2003
Financial Reports 2001/2002
Press Releases
Capital Market Transactions
Company Presentation
Corporate Documents
Financial reports for the 2007/2008 financial year
(1 April 2007 to 31 March 2008)
Annual Report 2007/2008
»
Download PDF-Document
Excerpts:
»
Chairman’s Letter
»
Management Report
»
Investment Guidelines
»
Corporate Governance
»
Consolidated Financial Statements
Quarterly Report December 2007
»
Download PDF-Document
Quarterly Report
September
2007
»
Download PDF-Document
Quarterly Report June 2007
»
Download PDF-Document
News
Press Releases
»
HBM BioVentures Quarterly Report as at 30 June 2010
»
HBM BioVentures’ largest public investment – Micrus – acquired
by Johnson & Johnson
»
HBM BioVentures sells USD hedging position at a profit
»
Shareholders’ meeting approves all proposals by Board of Directors by large majority; Hans Peter Hasler appointed as new Chairman of the Board of Directors; Astellas, which recently acquired OSI Pharmaceuticals, will retain HBM BioVentures shares and intensify cooperation
»
Archive
Financial Reports
»
Quarterly Report June 2010
»
Annual Report 2009/2010
»
Archive
Share Price
SIX Swiss Exchange Ticker
HBMN
Key Figures
as at 31.8.2010
CHF
NAV
per share
62.58
Net assets
616 Mio.
Search
News Registration
Sign up now